AI Automation for Literature Review in Pharma and Life Sciences
Shows a concrete, end-to-end automation blueprint for literature review tasks in pharma and life sciences, including data sources, AI steps, and a worked example.
By Suhas Bhairav · Updated
Direct Answer
AI automation for literature review in pharma and life sciences means automating search, filtering, extraction, and synthesis tasks while preserving expert interpretation and oversight. It identifies key article sources, standardizes metadata, and generates structured summaries for researchers to validate, annotate, and decide on next steps.
Best for: Librarians, researchers, and automation engineers who run this workflow and ensure compliance with regulatory review standards.
What You Can Automate in Literature Review in Pharma and Life Sciences
Literature search
AI scans databases like PubMed, Scopus, and clinical trial registries, applies inclusion criteria, and returns a ranked list of relevant articles with metadata and abstracts.
Eligibility screening
AI screens titles and abstracts against predefined criteria, flags ambiguities for human review, and records decisions in the project workspace.
Data extraction
AI extracts study design, population, interventions, outcomes, and key results from full texts and PDFs into a structured extraction form.
Citation capture
AI records DOIs, PMIDs, authors, journals, and keywords into a centralized reference manager and links to full texts.
Quality assessment
AI applies risk-of-bias checklists and study quality indicators, annotating concerns for human review in a structured report.
Synthesis drafting
AI compiles structured summaries, compares findings across studies, and drafts a narrative synthesis outline for expert writing and validation.
How It Works
Trigger
A new literature query is defined in the project workspace, specifying diseases, interventions, and outcomes, with inclusion/exclusion criteria and target databases.
Gather data
Automated fetches articles, retrieves full texts where available, and collects abstracts, metadata, and citation information into a centralized repository.
AI decision
AI screens material, extracts key data fields, assesses study quality, and prioritizes articles for human review based on relevance and reliability.
Action in system
Structured data is stored in the reference manager and extraction sheets; summaries and annotations are attached to each record for collaboration.
Human review
A reviewer confirms selections, adjusts inclusion criteria, and approves the final synthesis outline before drafting or publishing.
Worked Example
Automated screening and extraction for a phase II literature review on a new oncology agent
Illustrative scenario with sample data.
Scenario
A pharmaceutical company conducts a phase II review of randomized trials for a novel oncology agent targeting a specific cancer subtype, aiming to inform study design and regulatory submissions.
Input
Query includes disease: colorectal cancer; intervention: agent X; outcomes: overall survival, progression-free survival; databases: PubMed, Embase; date range: 2019-2025; inclusion criteria: RCTs, adult participants, English full text; exclusions: non-randomized, preclinical.
What the automation does
- AI retrieves 200 articles from PubMed and Embase, filters by study type and language, and flags 120 as potentially eligible based on title/abstract matching criteria.
- AI extracts study design, population, intervention details, comparator, and outcomes into a structured form; it also records risk-of-bias indicators for each study.
- AI ranks studies and compiles a tabular evidence map highlighting consistency and gaps across trials, then drafts a concise 2-page summary.
- Reviewer reviews the automated outputs, validates data fields, resolves discrepancies, and approves the final structured evidence report for internal review.
Output
Record set includes 110 eligible studies with extracted data fields: study_id, title, authors, year, design, N, population, intervention, comparator, doses, outcomes, risk_of_bias, and a 2-page narrative summary.
Human decision
The reviewer checks study eligibility flags, confirms the extraction accuracy, and approves inclusion decisions for the final synthesis before drafting the narrative and figures.
What You Need
- Access to a centralized literature workspace with project folders and a shared database.
- Connections to PubMed, Embase, and clinical trial registries in a read mode, plus a license for reference management software.
- Defined inclusion/exclusion criteria and data extraction templates.
- A role-based access plan and audit trail for compliance and review.
Where People Stay in Charge
- Decisions regarding study eligibility and inclusion criteria must stay with a qualified reviewer to prevent biased evidence selection.
- Quality assessments and risk-of-bias conclusions require human judgment and can not be fully automated without oversight.
- Final synthesis and reporting require expert authorization before publication or regulatory submission.
FAQ
What can be automated in literature reviews for pharma and life sciences?
AI can automate search, screening, data extraction, citation capture, quality assessment, and synthesis drafting. Humans oversee interpretation, resolve ambiguities, and approve final reports, ensuring regulatory and methodological standards are met.
How does data extraction work in this workflow?
Automated extraction reads full texts and extracts study design, population, interventions, outcomes, and results into structured fields. Humans review and correct any misreadings or ambiguities before inclusion in the synthesis.
What systems are involved in running this automation?
A centralized literature workspace, reference manager, database connectors for PubMed and Embase, and a structured extraction template are used. Access controls and an audit trail ensure compliance and traceability.
What must a human reviewer verify before finalizing a review?
A reviewer checks eligibility decisions, confirms extracted data accuracy, assesses risk of bias notes, and approves the final narrative outline and figures for publication readiness.